Transfer‐molded wrappable microneedle meshes for perivascular drug delivery

&NA; After surgical procedures such as coronary/peripheral bypass grafting or endarterectomy for the treatment of organ ischemia derived from atherosclerosis, intimal hyperplasia (IH) which leads to restenosis or occlusion at the site of graft anastomosis frequently occurs. In order to inhibit IH caused by abnormal growth of smooth muscle cells (SMCs) in tunica media, various perivascular drug delivery devices are reported for delivery of anti‐proliferation drugs into vascular tissue. However, there still remain conflicting requirements such as local and unidirectional delivery vs device porosity, and conformal tight device installation vs pulsatile expansion and constriction of blood vessels. In this study, a biodegradable microneedle (MN) array is developed on a flexible woven surgical mesh using a transfer molding method. Mechanical properties of ‘wrappable’ MN meshes are investigated and compared to the properties of blood vessels. Ex vivo and in vivo animal studies demonstrate enhanced drug delivery efficiency, efficacy for IH reduction, and safety of MN mesh. In particular, MN mesh showed significantly reduced neointiamal formation (11.1%) compared to other competitive groups (23.7 and 22.2%) after 4‐week in vivo animal study. Additionally, wrappable MN meshes effectively suppressed side effects such as IH due to mechanical constriction, loss of toxic drug to the surroundings, and cell death that were frequently observed with other previous perivascular drug delivery devices. Graphical abstract Figure. No caption available.

[1]  K. Kent,et al.  Periadventitial drug delivery for the prevention of intimal hyperplasia following open surgery. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Göran Stemme,et al.  Flexible and Stretchable Microneedle Patches with Integrated Rigid Stainless Steel Microneedles for Transdermal Biointerfacing , 2016, PloS one.

[3]  Michael Joner,et al.  Drug-Eluting Stent and Coronary Thrombosis: Biological Mechanisms and Clinical Implications , 2007, Circulation.

[4]  K. Kent,et al.  A rapamycin-releasing perivascular polymeric sheath produces highly effective inhibition of intimal hyperplasia. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[5]  J. Eidt,et al.  Hyperhomocysteinemia increases intimal hyperplasia in a rat carotid endarterectomy model. , 1998, Journal of vascular surgery.

[6]  Jung-Hwan Park,et al.  Microneedles for drug and vaccine delivery. , 2012, Advanced drug delivery reviews.

[7]  B. Cortese,et al.  Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO Study , 2010, Heart.

[8]  Michael L. Reed,et al.  The evolution from convex corner undercut towards microneedle formation: theory and experimental verification , 2006 .

[9]  Wei Chen,et al.  Improved polyvinylpyrrolidone microneedle arrays with non-stoichiometric cyclodextrin. , 2014, Journal of materials chemistry. B.

[10]  Hye Rim Cho,et al.  A graphene-based electrochemical device with thermoresponsive microneedles for diabetes monitoring and therapy. , 2016, Nature nanotechnology.

[11]  N. Weissman,et al.  Paclitaxel Coating Reduces In-Stent Intimal Hyperplasia in Human Coronary Arteries: A Serial Volumetric Intravascular Ultrasound Analysis From the ASian Paclitaxel-Eluting Stent Clinical Trial (ASPECT) , 2003, Circulation.

[12]  S. Pocock,et al.  Incidence , , 2018 .

[13]  A. Marks,et al.  Drug-eluting stents. , 2004, Annual review of medicine.

[14]  Deenu Kanjickal,et al.  Polymeric sustained local drug delivery system for the prevention of vascular intimal hyperplasia. , 2004, Journal of biomedical materials research. Part A.

[15]  S. Bölükbas,et al.  Drug-eluting Stents , 2009, Der Chirurg.

[16]  A. Cheung,et al.  A biodegradable perivascular wrap for controlled, local and directed drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[17]  W. Ryu,et al.  A Biodegradable Microneedle Cuff for Comparison of Drug Effects through Perivascular Delivery to Balloon-Injured Arteries , 2017, Polymers.

[18]  B. Abella,et al.  Paclitaxel Stent Coating Inhibits Neointimal Hyperplasia at 4 Weeks in a Porcine Model of Coronary Restenosis , 2001, Circulation.

[19]  T. Stieglitz,et al.  Characterization of parylene C as an encapsulation material for implanted neural prostheses. , 2010, Journal of biomedical materials research. Part B, Applied biomaterials.

[20]  Benno J. Rensing,et al.  Sustained Suppression of Neointimal Proliferation by Sirolimus-Eluting Stents: One-Year Angiographic and Intravascular Ultrasound Follow-Up , 2001, Circulation.

[21]  D. Scheinert,et al.  First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. , 2011, Journal of the American College of Cardiology.

[22]  A. Cheung,et al.  Correlation of tissue drug concentrations with in vivo magnetic resonance images of polymer drug depot around arteriovenous graft. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[23]  Wei Xia,et al.  Bioceramic microneedles with flexible and self-swelling substrate. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  Mark R Prausnitz,et al.  Microneedles for transdermal drug delivery. , 2004, Advanced drug delivery reviews.

[25]  M. Kibbe,et al.  Poly(diol-co-citrate)s as novel elastomeric perivascular wraps for the reduction of neointimal hyperplasia. , 2011, Macromolecular bioscience.

[26]  Zhiyuan Hu,et al.  A flexible microneedle array as low-voltage electroporation electrodes for in vivo DNA and siRNA delivery. , 2014, Lab on a Chip.

[27]  Xudong Shi,et al.  Periadventitial Application of Rapamycin-Loaded Nanoparticles Produces Sustained Inhibition of Vascular Restenosis , 2014, PloS one.

[28]  W. Ryu,et al.  Spatially discrete thermal drawing of biodegradable microneedles for vascular drug delivery. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[29]  Patricia B. Williams,et al.  Noninvasive Blood Pressure Determination in the Rabbit with a Doppler Ultrasound Probe , 1979, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[30]  B. Gersh.  Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents , 2006 .

[31]  G. Pastorin,et al.  Development of a disposable and flexible microneedle-fluidic-system with finger driven drug loading and delivery functions , 2015, 2015 Transducers - 2015 18th International Conference on Solid-State Sensors, Actuators and Microsystems (TRANSDUCERS).

[32]  N. Kipshidze,et al.  Safety and efficacy of local periadventitial delivery of sirolimus for improving hemodialysis graft patency: first human experience with a sirolimus-eluting collagen membrane (Coll-R). , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  Peng Xue,et al.  Flexible PEGDA-based microneedle patches with detachable PVP–CD arrowheads for transdermal drug delivery , 2015 .

[34]  M. Capek,et al.  A perivascular system releasing sirolimus prevented intimal hyperplasia in a rabbit model in a medium-term study. , 2012, International journal of pharmaceutics.

[35]  Eben Alsberg,et al.  Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Deenu Kanjickal,et al.  Sustained local drug delivery from a novel polymeric ring to inhibit intimal hyperplasia. , 2009, Journal of biomedical materials research. Part A.

[37]  Jin Bum Kim,et al.  Curved biodegradable microneedles for vascular drug delivery. , 2012, Small.

[38]  M. Daemen,et al.  Intimal hyperplasia in vascular grafts. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[39]  E. Kholmovski,et al.  In vivo evaluation of the delivery and efficacy of a sirolimus-laden polymer gel for inhibition of hyperplasia in a porcine model of arteriovenous hemodialysis graft stenosis. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[40]  L. Bačáková,et al.  Perivascular sirolimus-delivery system. , 2011, International journal of pharmaceutics.

[41]  Giorgia Pastorin,et al.  Toward Self‐Powered Wearable Adhesive Skin Patch with Bendable Microneedle Array for Transdermal Drug Delivery , 2016, Advanced science.

[42]  G. Angelini,et al.  Periadventitial Rapamycin-Eluting Microbeads Promote Vein Graft Disease in Long-Term Pig Vein-Into-Artery Interposition Grafts , 2010, Circulation. Cardiovascular interventions.

[43]  Qingbo Xu,et al.  Adventitial biology: differentiation and function. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[44]  R. Schwartz,et al.  Beneficial effects of banding on venous intimal-medial hyperplasia in arteriovenous loop grafts. , 1989, American journal of surgery.

[45]  M. Majesky.  Adventitia and perivascular cells. , 2015, Arteriosclerosis, thrombosis, and vascular biology.

[46]  R Berguer,et al.  In vitro characterisation of physiological and maximum elastic modulus of ascending thoracic aortic aneurysms using uniaxial tensile testing. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[47]  Spencer B. King,et al.  Restenosis After Coronary Angioplasty: Potential Biologic Determinants and Role of Intimal Hyperplasia , 1989 .

[48]  Ashish A. Pandya,et al.  Rapidly–Dissolvable Microneedle Patches Via a Highly Scalable and Reproducible Soft Lithography Approach , 2013, Advanced materials.

[49]  G. Laufer,et al.  Perivascular administration of drugs and genes as a means of reducing vein graft failure. , 2012, Current opinion in pharmacology.

[50]  H. Anderson,et al.  Restenosis after coronary angioplasty. , 1993, Journal of interventional cardiology.

[51]  M. Capek,et al.  A periadventitial sirolimus-releasing mesh decreased intimal hyperplasia in a rabbit model. , 2011, Physiological research.

[52]  W. Ryu,et al.  Perivascular biodegradable microneedle cuff for reduction of neointima formation after vascular injury. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[53]  Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries: A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study , 2001 .

[54]  Valeria Chiono,et al.  An Overview of Poly(lactic-co-glycolic) Acid (PLGA)-Based Biomaterials for Bone Tissue Engineering , 2014, International journal of molecular sciences.

[55]  P. Pattynama,et al.  Sirolimus-Eluting Stents to Abolish Intimal Hyperplasia and Improve Flow in Porcine Arteriovenous Grafts: A 4-Week Follow-Up Study , 2005, Circulation.

[56]  P. Quax,et al.  Arteriovenous access failure: more than just intimal hyperplasia? , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[57]  Zhuolin Xiang,et al.  A flexible three-dimensional electrode mesh: An enabling technology for wireless brain–computer interface prostheses , 2016, Microsystems & Nanoengineering.